Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 5 years
- Director since
- 2024
5 years of board service in total across 2 boards, counting each seat separately. Longest: Zentalis Pharmaceuticals Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Context Therapeutics Inc. June 24, 2026100.0%
-
Zentalis Pharmaceuticals Inc. June 17, 202577.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 16, 2026 | Zentalis Pharmaceuticals Inc. | Grant or award | +57,100 | — | — |
| Jun 17, 2025 | Zentalis Pharmaceuticals Inc. | Grant or award | +57,603 | — | — |
| Jan 31, 2025 | Zentalis Pharmaceuticals Inc. | Open-market purchase | +14,200 | $1.76 | $24,992 |
| May 24, 2024 | Zentalis Pharmaceuticals Inc. | Grant or award | +72,481 | — | — |
Questions about Luke Nathaniel Walker
What boards is Luke Nathaniel Walker on?
Luke Nathaniel Walker sits on the boards of Context Therapeutics Inc. and Zentalis Pharmaceuticals Inc.
How long has Luke Nathaniel Walker served on boards?
Our records show at least 5 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.